Christoph A. Merten PhD

Christoph is a principal investigator at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. His s group pioneered the use of droplet-microfluidics for large-scale cell-based assays: After publishing a seminal paper in 2008 (~600 citations) his lab also demonstrated the screening of therapeutic antibodies in droplets for the very first time (2012).

Christoph is an inventor on a total of 14 patents (four of them with him as the sole inventor). Prior to founding Velabs, he successfully commercialized microfluidic technology and worked as a consultant for many years. He holds a Ph.D. in biochemistry (directed evolution) and did postdoctoral studies at the MRC Laboratory of Molecular Biology (Cambridge, UK) and the Institute de Science et d'Ingénierie Supramoléculaires (ISIS) in Strasbourg, France.